Evrofarma SA (ATH:EVROF)
4.060
-0.010 (-0.25%)
Aug 21, 2026, 4:59 PM EET
43.97% (1Y)
| Market Cap | 54.96M +47.8% |
| Revenue (ttm) | 49.44M +8.1% |
| Net Income | 3.53M +54.6% |
| EPS | 0.26 +54.7% |
| Shares Out | 13.67M |
| PE Ratio | 15.59 |
| Forward PE | n/a |
| Dividend | 0.06 (1.44%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 3,874 |
| Open | 4.070 |
| Previous Close | 4.070 |
| Day's Range | 3.920 - 4.100 |
| 52-Week Range | 2.380 - 4.230 |
| Beta | 0.69 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 25, 2026 |